Holen Sie sich die Stockscreener-App
4.36
6.60%
0.27
Vorhandelsmarkt:
4.36
Schlusskurs vom Vortag:
$4.09
Offen:
$3.96
24-Stunden-Volumen:
399.59K
Relative Volume:
1.32
Marktkapitalisierung:
$235.47M
Einnahmen:
$77.36M
Nettoeinkommen (Verlust:
$-38.43M
KGV:
-5.8855
EPS:
-0.7408
Netto-Cashflow:
$-29.92M
1W Leistung:
+18.16%
1M Leistung:
+25.65%
6M Leistung:
-6.44%
1J Leistung:
+63.91%
1-Tages-Spanne:
$3.96
$4.37
1-Wochen-Bereich:
$3.70
$4.37
52-Wochen-Spanne:
$2.5092
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.36 | 220.88M | 77.36M | -38.43M | -29.92M | -0.7408 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences wins $34M patent ruling against Alcon - MSN
KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus
SGHT: Momentum builds for interventional glaucoma and dry eye, with innovation and adoption accelerating - TradingView
If You Invested $1,000 in Sight Sciences, Inc. (SGHT) - Stock Titan
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Sight Sciences CFO Rodberg sells $25,670 in shares By Investing.com - Investing.com Australia
Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com Canada
Sight Sciences CLO Hayden sells shares worth $48,851 - Investing.com
Sight Sciences CFO Rodberg sells $25,670 in shares - Investing.com
Sight Sciences (NASDAQ:SGHT) CFO James Rodberg Sells 7,231 Shares of Stock - MarketBeat
Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan
Sight Sciences (SGHT) legal chief sells 13,761 shares for RSU tax obligations - Stock Titan
KCK Ltd. reports 1.44M shares in Sight Sciences (SGHT) — 2.7% stake - Stock Titan
Bull Bear: Does ITRI offer margin of safetyWeekly Profit Analysis & Smart Investment Allocation Tips - baoquankhu1.vn
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Cuts Target Price to $4.35 - Moomoo
Affiliate notice: SGHT (NASDAQ: SGHT) proposes common-share sale tied to vesting - Stock Titan
SGHT (NASDAQ: SGHT) sale notice: 13,761 restricted shares vesting - Stock Titan
Published on: 2026-04-05 14:40:16 - baoquankhu1.vn
SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) - Investing.com Australia
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells 8,168 Shares of Stock - MarketBeat
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) By Investing.com - Investing.com South Africa
Sight Sciences (NASDAQ:SGHT) EVP Brenton Taylor Sells 2,869 Shares - MarketBeat
Sight Sciences (NASDAQ:SGHT) CEO Sells 29,244 Shares - MarketBeat
Sight Sciences CEO Badawi sells $108k in shares By Investing.com - Investing.com India
[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan
Sight Sciences CEO Badawi sells $108k in shares - Investing.com
Sight Sciences (SGHT) CTO tax-related sale of 8,168 shares disclosed - Stock Titan
Sight Sciences (SGHT) EVP Brenton sells 2,869 shares for RSU tax obligations - Stock Titan
Sight Sciences executive plans $90K stock sale - National Today
Alison Bauerlein plans sale of 25,874 shares (SGHT) - Stock Titan
Insider sale notice: SGHT (NASDAQ: SGHT) 8,168 restricted shares - Stock Titan
SGHT PE Ratio & Valuation, Is SGHT Overvalued - Intellectia AI
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - The Manila Times
SGHT (NASDAQ: SGHT) files Form 144 to sell 29,244 vested shares - Stock Titan
Proposed share sales at SGHT (NASDAQ: SGHT) include 2,293 and 576 shares - Stock Titan
Aug Rallies: Is Sight Sciences Inc a top pick in the sectorTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):